help button home button Am J Pathol R & D Systems
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fujikawa, T.
Right arrow Articles by Petersen, B. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fujikawa, T.
Right arrow Articles by Petersen, B. E.
(American Journal of Pathology. 2005;166:1781-1791.)
© 2005 American Society for Investigative Pathology

Teratoma Formation Leads to Failure of Treatment for Type I Diabetes Using Embryonic Stem Cell-Derived Insulin-Producing Cells

Takahisa Fujikawa, Seh-Hoon Oh, Liya Pi, Heather M. Hatch, Tom Shupe and Bryon E. Petersen

From the Department of Pathology, Immunology, and Laboratory Medicine, and Program in Stem Cell Biology and Regenerative Medicine, College of Medicine, University of Florida, Gainesville, Florida

Embryonic stem (ES) cells have been proposed to be a powerful tool in the study of pancreatic disease, as well as a potential source for cell replacement therapy in the treatment of diabetes. However, data demonstrating the feasibility of using pancreatic islet-like cells differentiated from ES cells remain controversial. In this study we characterized ES cell-derived insulin-expressing cells and assessed their suitability for the treatment of type I diabetes. ES cell-derived insulin-stained cell clusters expressed insulin mRNA and transcription factors associated with pancreatic development. The majority of insulin-positive cells in the clusters also showed immunoreactivity for C-peptide. Insulin was stored in the cytoplasm and released into the culture medium in a glucose-dependent manner. When the cultured cells were transplanted into diabetic mice, they reversed the hyperglycemic state for ~3 weeks, but the rescue failed due to immature teratoma formation. Our studies demonstrate that reversal of hyperglycemia by transplantation of ES cell-derived insulin-producing cells is possible. However, the risk of teratoma formation would need to be eliminated before ES cell-based therapies for the treatment of diabetes are considered.





This article has been cited by other articles:


Home page
J EndocrinolHome page
M. Zhao, S. A Amiel, M. R Christie, P. Muiesan, P. Srinivasan, W. Littlejohn, M. Rela, M. Arno, N. Heaton, and G. C. Huang
Evidence for the presence of stem cell-like progenitor cells in human adult pancreas
J. Endocrinol., December 1, 2007; 195(3): 407 - 414.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
M. Takenaga, M. Fukumoto, and Y. Hori
Regulated Nodal signaling promotes differentiation of the definitive endoderm and mesoderm from ES cells
J. Cell Sci., June 15, 2007; 120(12): 2078 - 2090.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
A. M Ackermann and M. Gannon
Molecular regulation of pancreatic {beta}-cell mass development, maintenance, and expansion
J. Mol. Endocrinol., February 1, 2007; 38(2): 193 - 206.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. H. Lee, M. J. Seo, R. L. Reger, J. L. Spees, A. A. Pulin, S. D. Olson, and D. J. Prockop
Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice
PNAS, November 14, 2006; 103(46): 17438 - 17443.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
M. Mimeault and S. K. Batra
Concise Review: Recent Advances on the Significance of Stem Cells in Tissue Regeneration and Cancer Therapies
Stem Cells, November 1, 2006; 24(11): 2319 - 2345.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. A. Koch, C. E. Jordan, and J. L. Platt
Complement-Dependent Control of Teratoma Formation by Embryonic Stem Cells
J. Immunol., October 1, 2006; 177(7): 4803 - 4809.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
V. J. Hall, P. Stojkovic, and M. Stojkovic
Using Therapeutic Cloning to Fight Human Disease: A Conundrum or Reality?
Stem Cells, July 1, 2006; 24(7): 1628 - 1637.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
M. Y. Gordon, N. Levicar, M. Pai, P. Bachellier, I. Dimarakis, F. Al-Allaf, H. M'Hamdi, T. Thalji, J. P. Welsh, S. B. Marley, et al.
Characterization and Clinical Application of Human CD34+ Stem/Progenitor Cell Populations Mobilized into the Blood by Granulocyte Colony-Stimulating Factor
Stem Cells, July 1, 2006; 24(7): 1822 - 1830.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
H. Shibata, N. Ageyama, Y. Tanaka, Y. Kishi, K. Sasaki, S. Nakamura, S.-i. Muramatsu, S. Hayashi, Y. Kitano, K. Terao, et al.
Improved Safety of Hematopoietic Transplantation with Monkey Embryonic Stem Cells in the Allogeneic Setting
Stem Cells, June 1, 2006; 24(6): 1450 - 1457.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
C. E. Murry, H. Reinecke, and L. M. Pabon
Regeneration Gaps: Observations on Stem Cells and Cardiac Repair
J. Am. Coll. Cardiol., May 2, 2006; 47(9): 1777 - 1785.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the American Society for Investigative Pathology.